Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Helicobacter pylori | 12 | 2019 | 54 | 3.010 |
Why?
|
| Helicobacter Infections | 5 | 2020 | 40 | 1.740 |
Why?
|
| Peritoneal Neoplasms | 3 | 2020 | 23 | 0.980 |
Why?
|
| Anti-Bacterial Agents | 6 | 2019 | 1026 | 0.760 |
Why?
|
| Bacteroidetes | 1 | 2020 | 5 | 0.750 |
Why?
|
| Bacterial Adhesion | 2 | 2011 | 33 | 0.720 |
Why?
|
| Phylogeny | 2 | 2020 | 196 | 0.720 |
Why?
|
| Premenopause | 1 | 2019 | 57 | 0.710 |
Why?
|
| Culture Media | 3 | 2013 | 155 | 0.700 |
Why?
|
| Postmenopause | 1 | 2019 | 92 | 0.690 |
Why?
|
| Colitis | 1 | 2020 | 156 | 0.680 |
Why?
|
| Pseudomyxoma Peritonei | 4 | 2021 | 8 | 0.610 |
Why?
|
| Atherosclerosis | 1 | 2019 | 204 | 0.600 |
Why?
|
| Host-Pathogen Interactions | 3 | 2020 | 69 | 0.550 |
Why?
|
| Bacterial Proteins | 6 | 2011 | 244 | 0.550 |
Why?
|
| Diet | 1 | 2019 | 513 | 0.550 |
Why?
|
| MicroRNAs | 1 | 2020 | 447 | 0.530 |
Why?
|
| Helicobacter | 2 | 2020 | 5 | 0.480 |
Why?
|
| Cholesterol | 2 | 2011 | 331 | 0.440 |
Why?
|
| Adhesins, Bacterial | 1 | 2011 | 13 | 0.400 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2011 | 21 | 0.400 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2011 | 21 | 0.400 |
Why?
|
| Laminin | 1 | 2011 | 62 | 0.400 |
Why?
|
| Iron | 2 | 2010 | 197 | 0.380 |
Why?
|
| Serum | 1 | 2007 | 24 | 0.320 |
Why?
|
| Arginase | 4 | 2011 | 15 | 0.310 |
Why?
|
| Biofilms | 1 | 2007 | 72 | 0.300 |
Why?
|
| Microbiota | 2 | 2020 | 79 | 0.280 |
Why?
|
| Animals | 10 | 2020 | 20877 | 0.250 |
Why?
|
| Prevalence | 2 | 2019 | 1609 | 0.220 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2020 | 85 | 0.210 |
Why?
|
| Sigma Factor | 1 | 2002 | 5 | 0.210 |
Why?
|
| Salmonella typhimurium | 1 | 2002 | 15 | 0.210 |
Why?
|
| Sequence Analysis, DNA | 2 | 2020 | 208 | 0.200 |
Why?
|
| Streptomyces | 1 | 2021 | 15 | 0.200 |
Why?
|
| Anthraquinones | 1 | 2021 | 18 | 0.200 |
Why?
|
| Vitamin K 2 | 1 | 2020 | 2 | 0.190 |
Why?
|
| Baltimore | 1 | 2020 | 34 | 0.190 |
Why?
|
| Glycolipids | 1 | 2020 | 20 | 0.190 |
Why?
|
| Base Composition | 1 | 2020 | 22 | 0.190 |
Why?
|
| Phosphatidylethanolamines | 1 | 2020 | 20 | 0.190 |
Why?
|
| Bacterial Typing Techniques | 1 | 2020 | 19 | 0.190 |
Why?
|
| Dextran Sulfate | 1 | 2020 | 88 | 0.190 |
Why?
|
| Mutation | 5 | 2011 | 1213 | 0.180 |
Why?
|
| Macaca fascicularis | 1 | 2019 | 31 | 0.180 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2011 | 98 | 0.180 |
Why?
|
| DNA, Bacterial | 1 | 2020 | 150 | 0.180 |
Why?
|
| Colon | 1 | 2020 | 168 | 0.180 |
Why?
|
| Indoles | 1 | 2020 | 146 | 0.180 |
Why?
|
| Antioxidants | 1 | 2002 | 304 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 2790 | 0.170 |
Why?
|
| Fatty Acids | 1 | 2020 | 222 | 0.170 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2019 | 3 | 0.170 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2020 | 121 | 0.170 |
Why?
|
| Arteries | 1 | 2019 | 108 | 0.170 |
Why?
|
| Hyperthermia, Induced | 1 | 2019 | 53 | 0.160 |
Why?
|
| Inflammation | 2 | 2017 | 1030 | 0.160 |
Why?
|
| Mice | 6 | 2020 | 8472 | 0.160 |
Why?
|
| Lipids | 1 | 2019 | 298 | 0.160 |
Why?
|
| Intestinal Diseases | 1 | 2017 | 25 | 0.150 |
Why?
|
| Persian Gulf Syndrome | 1 | 2017 | 27 | 0.150 |
Why?
|
| Enterobacteriaceae | 1 | 2016 | 29 | 0.150 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2016 | 25 | 0.150 |
Why?
|
| beta-Lactams | 1 | 2016 | 29 | 0.150 |
Why?
|
| Bacteria | 2 | 2020 | 193 | 0.140 |
Why?
|
| Fluoroquinolones | 1 | 2016 | 49 | 0.140 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2017 | 114 | 0.140 |
Why?
|
| Cytokines | 1 | 2020 | 866 | 0.140 |
Why?
|
| Frontal Lobe | 1 | 2017 | 156 | 0.130 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 2550 | 0.130 |
Why?
|
| Humans | 12 | 2021 | 68525 | 0.130 |
Why?
|
| Drug Resistance, Viral | 1 | 2014 | 14 | 0.130 |
Why?
|
| Virulence | 1 | 2014 | 51 | 0.130 |
Why?
|
| Bacteremia | 1 | 2016 | 155 | 0.130 |
Why?
|
| Stomach Diseases | 1 | 2014 | 22 | 0.130 |
Why?
|
| Biomarkers | 1 | 2019 | 1593 | 0.120 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2013 | 18 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1070 | 0.120 |
Why?
|
| Escherichia coli | 3 | 2011 | 368 | 0.110 |
Why?
|
| beta Catenin | 1 | 2013 | 73 | 0.110 |
Why?
|
| Plasmids | 2 | 2011 | 258 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2013 | 163 | 0.100 |
Why?
|
| Bismuth | 1 | 2011 | 2 | 0.100 |
Why?
|
| Cathelicidins | 1 | 2011 | 11 | 0.100 |
Why?
|
| Lipid A | 1 | 2011 | 9 | 0.100 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2011 | 8 | 0.100 |
Why?
|
| Cell Wall | 1 | 2011 | 21 | 0.100 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2011 | 22 | 0.100 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2011 | 32 | 0.100 |
Why?
|
| Salicylates | 1 | 2011 | 22 | 0.100 |
Why?
|
| Gerbillinae | 1 | 2011 | 156 | 0.100 |
Why?
|
| Gastric Mucosa | 1 | 2011 | 77 | 0.100 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2011 | 85 | 0.100 |
Why?
|
| Bile Acids and Salts | 1 | 2010 | 19 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 785 | 0.100 |
Why?
|
| Folic Acid | 1 | 2011 | 121 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 1465 | 0.090 |
Why?
|
| Antifungal Agents | 1 | 2011 | 108 | 0.090 |
Why?
|
| Lactoferrin | 1 | 2010 | 6 | 0.090 |
Why?
|
| Incidence | 1 | 2014 | 1582 | 0.090 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 95 | 0.090 |
Why?
|
| DNA Replication | 1 | 2011 | 167 | 0.090 |
Why?
|
| Steroids | 1 | 2010 | 84 | 0.090 |
Why?
|
| Hemoglobins | 1 | 2010 | 120 | 0.090 |
Why?
|
| Transferrin | 1 | 2010 | 94 | 0.090 |
Why?
|
| Cattle | 1 | 2010 | 475 | 0.090 |
Why?
|
| Gene Expression | 1 | 2011 | 770 | 0.080 |
Why?
|
| Neoplasms | 1 | 2020 | 1660 | 0.080 |
Why?
|
| Risk Factors | 2 | 2016 | 5719 | 0.080 |
Why?
|
| Trypsin | 1 | 2007 | 64 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2014 | 7028 | 0.080 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2007 | 236 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2010 | 597 | 0.080 |
Why?
|
| Female | 4 | 2019 | 38015 | 0.070 |
Why?
|
| Genetic Complementation Test | 1 | 2006 | 35 | 0.070 |
Why?
|
| Culture Media, Serum-Free | 1 | 2006 | 35 | 0.070 |
Why?
|
| Salts | 1 | 2006 | 21 | 0.070 |
Why?
|
| Colony Count, Microbial | 1 | 2006 | 77 | 0.070 |
Why?
|
| Sodium Chloride | 1 | 2006 | 136 | 0.070 |
Why?
|
| Thioredoxins | 1 | 2005 | 26 | 0.070 |
Why?
|
| Nitrogen | 1 | 2005 | 57 | 0.070 |
Why?
|
| Amino Acids | 1 | 2006 | 131 | 0.070 |
Why?
|
| Molecular Structure | 2 | 2021 | 397 | 0.070 |
Why?
|
| Metals | 1 | 2006 | 100 | 0.070 |
Why?
|
| Vitamins | 1 | 2006 | 134 | 0.070 |
Why?
|
| Adenosine Triphosphate | 1 | 2006 | 314 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2019 | 951 | 0.060 |
Why?
|
| In Situ Hybridization | 2 | 2013 | 201 | 0.060 |
Why?
|
| Regulon | 1 | 2002 | 3 | 0.050 |
Why?
|
| Respiratory Burst | 1 | 2002 | 6 | 0.050 |
Why?
|
| Salmonella Infections, Animal | 1 | 2002 | 5 | 0.050 |
Why?
|
| Aerobiosis | 1 | 2002 | 19 | 0.050 |
Why?
|
| Oxidative Stress | 2 | 2005 | 718 | 0.050 |
Why?
|
| California | 1 | 2021 | 99 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 111 | 0.050 |
Why?
|
| Multigene Family | 1 | 2021 | 93 | 0.050 |
Why?
|
| Cell Division | 1 | 2002 | 541 | 0.050 |
Why?
|
| Geologic Sediments | 1 | 2021 | 75 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 532 | 0.050 |
Why?
|
| Oncogenic Viruses | 1 | 2020 | 1 | 0.050 |
Why?
|
| Gastritis | 1 | 2020 | 12 | 0.050 |
Why?
|
| Male | 4 | 2019 | 37281 | 0.050 |
Why?
|
| Probiotics | 1 | 2020 | 14 | 0.050 |
Why?
|
| Symbiosis | 1 | 2020 | 19 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2017 | 1692 | 0.050 |
Why?
|
| Tumor Virus Infections | 1 | 2020 | 32 | 0.050 |
Why?
|
| Biological Products | 1 | 2021 | 78 | 0.050 |
Why?
|
| Environmental Microbiology | 1 | 2020 | 25 | 0.050 |
Why?
|
| Stomach Neoplasms | 1 | 2020 | 64 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2020 | 260 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2020 | 107 | 0.040 |
Why?
|
| Cell Survival | 1 | 2002 | 901 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2020 | 212 | 0.040 |
Why?
|
| Claudin-2 | 1 | 2017 | 4 | 0.040 |
Why?
|
| Gulf War | 1 | 2017 | 22 | 0.040 |
Why?
|
| Endotoxemia | 1 | 2017 | 27 | 0.040 |
Why?
|
| Dysbiosis | 1 | 2017 | 24 | 0.040 |
Why?
|
| beta-Lactamases | 1 | 2016 | 33 | 0.040 |
Why?
|
| Intestines | 1 | 2017 | 114 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 1849 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 219 | 0.030 |
Why?
|
| Arginine | 2 | 2006 | 102 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 498 | 0.030 |
Why?
|
| Mucin-2 | 1 | 2013 | 3 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1046 | 0.030 |
Why?
|
| Mucins | 1 | 2013 | 22 | 0.030 |
Why?
|
| Lansoprazole | 1 | 2013 | 16 | 0.030 |
Why?
|
| Clarithromycin | 1 | 2013 | 11 | 0.030 |
Why?
|
| Amoxicillin | 1 | 2013 | 10 | 0.030 |
Why?
|
| Peritoneum | 1 | 2013 | 27 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2013 | 24 | 0.030 |
Why?
|
| Logistic Models | 1 | 2016 | 1419 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1548 | 0.030 |
Why?
|
| Protein Transport | 1 | 2013 | 280 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2013 | 305 | 0.030 |
Why?
|
| Ureohydrolases | 1 | 2011 | 1 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2013 | 523 | 0.030 |
Why?
|
| Urea | 1 | 2011 | 51 | 0.030 |
Why?
|
| Boronic Acids | 1 | 2011 | 40 | 0.030 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2010 | 49 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 1055 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2016 | 2004 | 0.020 |
Why?
|
| South Carolina | 1 | 2016 | 2750 | 0.020 |
Why?
|
| Prognosis | 1 | 2013 | 2093 | 0.020 |
Why?
|
| Chromosomes, Bacterial | 1 | 2006 | 7 | 0.020 |
Why?
|
| Transformation, Genetic | 1 | 2006 | 14 | 0.020 |
Why?
|
| Middle Aged | 2 | 2016 | 21119 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 181 | 0.020 |
Why?
|
| Urease | 1 | 2005 | 5 | 0.020 |
Why?
|
| Ultracentrifugation | 1 | 2005 | 10 | 0.020 |
Why?
|
| Chaperonin 60 | 1 | 2005 | 10 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2006 | 161 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2005 | 73 | 0.020 |
Why?
|
| Stomach | 1 | 2005 | 80 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 272 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2005 | 112 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2006 | 220 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 81 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 357 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2005 | 284 | 0.020 |
Why?
|
| Base Sequence | 1 | 2006 | 1015 | 0.020 |
Why?
|
| Mercaptoethanol | 1 | 2004 | 4 | 0.020 |
Why?
|
| Dithiothreitol | 1 | 2004 | 17 | 0.020 |
Why?
|
| Manganese | 1 | 2004 | 26 | 0.020 |
Why?
|
| Nickel | 1 | 2004 | 18 | 0.020 |
Why?
|
| Cobalt | 1 | 2004 | 37 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2016 | 7264 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2005 | 567 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 1446 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2004 | 152 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2005 | 499 | 0.010 |
Why?
|
| Rats | 1 | 2011 | 5300 | 0.010 |
Why?
|
| Temperature | 1 | 2004 | 340 | 0.010 |
Why?
|
| Peptides | 1 | 2005 | 455 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 618 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 791 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 742 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 954 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2005 | 617 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 659 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 14842 | 0.010 |
Why?
|